Latest Updates & News
The Future of Alzheimer’s Drugs: A New Direction
What did the research discover? A review of the 2024 Alzheimer's disease (AD) drug pipeline found 164 clinical trials testing 127 drugs, a decline from 187 trials and 141 drugs in 2023. The pipeline consists of: 48 trials in Phase 3 (testing 32 drugs) 90 trials in Phase 2 (testing 81 drugs) 26 trials in Phase 1 (testing 25 drugs) Most drugs in the pipeline aim to...
Understanding Sunscreen Safety and Effectiveness
What did the research discover? This study investigated how zinc oxide (ZnO) affects the safety and effectiveness of sunscreen ingredients when exposed to UV light. Sunscreens are generally tested based on individual ingredients, but their stability and safety depend on how these ingredients interact in a formulation. Researchers tested five common small-molecule...
FDA News Update: FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s...
How Blood Pressure Medications Could Lower Your Sodium Levels
What Did the Research Discover? Researchers in Denmark studied whether thiazide diuretics, a common type of blood pressure medication, increase the risk of low sodium levels (hyponatremia). They analyzed medical records from 2014 to 2018, looking at over 180,000 people who started different blood pressure treatments. The study found that people who took thiazide...
New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk: March 08, 2024
What is Wegovy prescribed for? Wegovy (generic name: semaglutide), pronounced “weh-Go-veeh,” is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems, to help them lose weight and keep it off. What is the name of the drug and what does it do? The...
FDA News Update: Martin A. Makary, M.D., M.P.H., Sworn in as FDA Commissioner
For Immediate Release: April 01, 2025 Renowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P.H., took the oath of office to become the 27th Commissioner of Food and Drugs. Dr. Makary was confirmed by a bipartisan vote of the U.S. Senate.“I am pleased to welcome Dr. Makary to the U.S. Department of Health and Human Services and the Food and...